Cellectis S.A. (CLLS) vs Rallybio Corporation (RLYB)
- Cellectis S.A. CLLS 1.01 −13.68%
- Rallybio Corporation RLYB 15.74 −1.01%
Cellectis S.A. and Rallybio Corporation are both Biotechnology companies. Cellectis S.A. and Rallybio Corporation are of similar size ($85.6M and $84.6M). Cellectis S.A. has negative trailing earnings, so its P/E is not meaningful; Rallybio Corporation trades at 3.3×. Rallybio Corporation grew revenue faster over the last twelve months: 1.18% against 0.61%. Rallybio Corporation has the higher net margin (0.00% vs −102.3%) and the lower return on invested capital (−944.4% vs 0.00%). Across the 16 metrics below, Rallybio Corporation leads on 14 and Cellectis S.A. on 2.
Valuation
Profitability
| Metric | CLLS | RLYB | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (90.88%) | 0.00% | 0.00% |
| Net margin | (102.34%) | 0.00% | 0.00% |
| Free cash flow margin | (68.63%) | 0.00% | 0.00% |
| Return on equity | (94.54%) | 34.52% | (50.12%) |
| Return on assets | (21.02%) | 32.85% | (45.60%) |
| Return on invested capital | 0.00% | (944.36%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack